17-48922935-C-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_023079.5(UBE2Z):c.892C>A(p.Gln298Lys) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000151 in 1,456,950 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_023079.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBE2Z | NM_023079.5 | c.892C>A | p.Gln298Lys | missense_variant, splice_region_variant | 6/7 | ENST00000360943.10 | NP_075567.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBE2Z | ENST00000360943.10 | c.892C>A | p.Gln298Lys | missense_variant, splice_region_variant | 6/7 | 1 | NM_023079.5 | ENSP00000354201.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000808 AC: 2AN: 247404Hom.: 0 AF XY: 0.00000748 AC XY: 1AN XY: 133608
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1456950Hom.: 0 Cov.: 32 AF XY: 0.0000193 AC XY: 14AN XY: 724280
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.892C>A (p.Q298K) alteration is located in exon 6 (coding exon 6) of the UBE2Z gene. This alteration results from a C to A substitution at nucleotide position 892, causing the glutamine (Q) at amino acid position 298 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at